A distinct subtype designated SCLC-I (inflamed) was subsequently identified, characterized by the absence of ASCL1, NEUROD1, and POU2F3 expression but elevated infiltration of immune cells (T cells, NK cells, macrophages). Here, POU2F3 is linked to small cell lung carcinoma.